Diagnostic tools are critical to keep everyone safe and track newly emerging variants
Data since 2015
71
clinical trials
undertaken
11
WHO recommendations supported
6,000+
health workers trained
32,500+
patients enrolled in studies
50m+
FIND-supported
products procured
3,000+
laboratories & testing
sites strengthened
West African countries come together to accelerate access to essential diagnostics across the region
ReadFIND to share COVID-19 testing experience with the President of Tanzania and other global experts at the World Innovation Summit for Health (WISH)
ReadFIND and Unitaid kick off new US$15.9 million grant to improve tuberculosis diagnosis in primary care and community settings with two calls for partners
ReadZaza is a social worker at Imedi HRS in Batumi, Georgia. With a lab specialist, Zaza does community outreach work conducting mobile counseling and screening for hepatitis C and other infectious diseases, using a lab-in-a van.
Read
This is Jennifer from the Research Institute for Tropical Medicine (RITM) in the Philippines, leading a workshop in Addis Ababa, Ethiopia, on quality testing for malaria rapid tests.
Read
Meet Sabir. He is 14 years old and lives in Surat, India. He loves studying and competed in the national Science Olympiad. He found out he had TB only after learning about the disease during a school visit by doctors.
Read
30 November 2022 – As the 2022 World Antimicrobial Awareness Week drew to a close last week, we were heartened to see the growing attention on the global health crisis of antimicrobial resistance (AMR), and left with renewed resolve for our part in the job still needed to stop this emergency from winding back the clock on a century of medical progress. As a landmark report in the Lancet revealed…
Read moretest
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aliquam aspernatur, at blanditiis culpa ea et expedita iure iusto laboriosam laborum maiores minima modi nostrum nulla officia quibusdam repellendus suscipit voluptatibus!
test tes test test test ttdfs
R&D
Clinical trials
Access
Geneva, Switzerland (HQ)
Hanoi, Viet Nam
New Delhi, India
Cape Town, South Africa
Nairobi, Kenya
